Inge Høgh Dufva
- Hematology top 1%
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 4
- Oncology top 10%
- Neutropenia and Cancer Infections 3
-
- Acute Lymphoblastic Leukemia research 6
-
- Epigenetics and DNA Methylation 3
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Claus Werenberg MarcherJan Maxwell NørgaardMarianne Tang SeverinsenLene Sofie Granfeldt ØstgårdMette NørgaardHenrik SengeløvLars KjeldsenMette Klarskov Andersen
- Cited by
- HematologyGeneticsOncology
- Partner nations
- DenmarkUnited KingdomSweden
In The Last Decade
Inge Høgh Dufva
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Hematology 843
- Genetics 309
- Oncology 264
- Public Health, Environmental and Occupational Health 265
- Molecular Biology 402
Countries citing papers authored by Inge Høgh Dufva
This map shows the geographic impact of Inge Høgh Dufva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Høgh Dufva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Høgh Dufva more than expected).
Fields of papers citing papers by Inge Høgh Dufva
This network shows the impact of papers produced by Inge Høgh Dufva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Høgh Dufva. The network helps show where Inge Høgh Dufva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inge Høgh Dufva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 10 | |
| 3 | 2020 | 4 | |
| 4 | 2019 | 58 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 26 | |
| 7 | 2015 | 279 | |
| 8 | 2014 | 52 | |
| 9 | 2014 | 56 | |
| 10 | 2014 | 65 | |
| 11 | 2014 | 44 | |
| 12 | 2012 | 0 | |
| 13 | 2011 | 43 | |
| 14 | 2011 | 1 | |
| 15 | 2010 | 11 | |
| 16 | 2009 | 3 | |
| 17 | 2009 | 100 | |
| 18 | 2008 | 1 | |
| 19 | 2006 | 71 | |
| 20 | 2000 | 20 |
About Inge Høgh Dufva
Inge Høgh Dufva is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Neutropenia and Cancer Infections (3 papers), Immunotherapy and Immune Responses (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (843 citations), Genetics (309 citations) and Oncology (264 citations). Inge Høgh Dufva has collaborated with scholars based in Denmark, United Kingdom and Sweden. Frequent co-authors include Claus Werenberg Marcher, Jan Maxwell Nørgaard, Marianne Tang Severinsen, Lene Sofie Granfeldt Østgård, Mette Nørgaard, Henrik Sengeløv, Lars Kjeldsen, Mette Klarskov Andersen, Keith Wheatley and Donald Milligan. Their work appears in journals such as Journal of Clinical Oncology, Blood and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.